Literature DB >> 27491726

Association of Gestational Hypertensive Disorders with Retinopathy of prematurity: A Systematic Review and Meta-analysis.

Priscilla Y L Chan1, Shu-Min Tang1, Sunny C L Au1,2, Shi-Song Rong1, Henry H W Lau1, Simon T C Ko2, Danny S C Ng1, Li Jia Chen1, Jason C S Yam1.   

Abstract

The role of gestational hypertensive disorders, which includes both pre-eclampsia and gestational hypertension, in the development of retinopathy of prematurity (ROP) has been controversial. Therefore, this systematic review and meta-analysis is to evaluate the association between gestational hypertensive disoders and ROP. Eligible studies published up to June 5, 2016 were identified from MEDLINE and EMBASE that evaluated the association between the two conditions. Totally 1142 published records were retrieved for screening, 925 of them eligible for detailed evaluation. Finally 19 studies involving 45281 infants with 5388 cases of ROP met our criteria for meta-analysis. Gestational hypertensive disorders were not associated with ROP (unadjusted OR: 0.89; P = 0.38; adjusted OR: 1.35; P = 0.18). Subgroup analyses also revealed no significant association between ROP with pre-eclampsia (unadjusted OR: 0.85; P = 0.29; adjusted OR:1.29; P = 0.28) or with gestational hypertension (unadjusted OR: 1.10; P = 0.39; adjusted OR: 1.25; P = 0.60) separately. Sensitivity analysis indicated our results were robust. We concluded no significant association between gestational hypertensive disorders and ROP. More large scale well-conducted prospective cohorts on the topic are needed.

Entities:  

Mesh:

Year:  2016        PMID: 27491726      PMCID: PMC4974497          DOI: 10.1038/srep30732

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature.

Authors:  J A Sterne; D Gavaghan; M Egger
Journal:  J Clin Epidemiol       Date:  2000-11       Impact factor: 6.437

2.  Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.

Authors:  Anne Cathrine Staff; Kristin Braekke; Guro M Johnsen; S Ananth Karumanchi; Nina Kittelsen Harsem
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

3.  Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.

Authors:  Anne Cathrine Staff; Kristin Braekke; Nina Kittelsen Harsem; Torstein Lyberg; Mette R Holthe
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-09-01       Impact factor: 2.435

Review 4.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

5.  Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore.

Authors:  V A Shah; C L Yeo; Y L F Ling; L Y Ho
Journal:  Ann Acad Med Singapore       Date:  2005-03       Impact factor: 2.473

6.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

7.  Risk factors in retinopathy of prematurity. a multivariate statistical analysis.

Authors:  V Seiberth; O Linderkamp
Journal:  Ophthalmologica       Date:  2000       Impact factor: 3.250

8.  Childhood blindness.

Authors:  P G Steinkuller; L Du; C Gilbert; A Foster; M L Collins; D K Coats
Journal:  J AAPOS       Date:  1999-02       Impact factor: 1.220

9.  Retinopathy of prematurity--risk factors.

Authors:  Ved P Gupta; Upreet Dhaliwal; Rohit Sharma; Piyush Gupta; Jolly Rohatgi
Journal:  Indian J Pediatr       Date:  2004-10       Impact factor: 1.967

Review 10.  Molecular mechanisms of preeclampsia.

Authors:  Walter P Mutter; S Ananth Karumanchi
Journal:  Microvasc Res       Date:  2007-05-06       Impact factor: 3.514

View more
  10 in total

1.  Pregnancy-induced hypertension and neonatal outcomes: a systematic review and meta-analysis.

Authors:  A Razak; A Florendo-Chin; L Banfield; M G Abdul Wahab; S McDonald; P S Shah; A Mukerji
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

2.  Neonatal outcomes of twins <29 weeks gestation of mothers with hypertensive disorders of pregnancy.

Authors:  Katherine Yurkiw; Belal Alshaikh; Shabih U Hasan; Deepak Louis; Julie Emberley; Martine Claveau; Marc Beltempo; Kamran Yusuf
Journal:  Pediatr Res       Date:  2022-04-05       Impact factor: 3.953

3.  The association of various obstetric and perinatal factors with retinopathy of prematurity.

Authors:  Ozlem Ozgur Gursoy; Hulusi Goktug Gurer; Ceren Yildiz Eren; Pinar Erdogan Ozgur; Huseyin Gursoy
Journal:  Int Ophthalmol       Date:  2022-03-29       Impact factor: 2.029

4.  Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks' gestation.

Authors:  Belal Alshaikh; Omar Salman; Nancy Soliman; Anna Ells; Kamran Yusuf
Journal:  BMJ Open Ophthalmol       Date:  2017-06-19

5.  Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity.

Authors:  Julia P Shulman; Cindy Weng; Jacob Wilkes; Tom Greene; M Elizabeth Hartnett
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

6.  Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis.

Authors:  Eduardo Villamor-Martinez; Giacomo Cavallaro; Genny Raffaeli; Owais M M Mohammed Rahim; Silvia Gulden; Amro M T Ghazi; Fabio Mosca; Pieter Degraeuwe; Eduardo Villamor
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

7.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

Review 8.  Role of cytokines and treatment algorithms in retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Curr Opin Ophthalmol       Date:  2017-05       Impact factor: 3.761

9.  Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials.

Authors:  Giacomo Cavallaro; Eduardo Villamor-Martínez; Luca Filippi; Fabio Mosca; Eduardo Villamor
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

Review 10.  Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.

Authors:  Mike Trott; Lee Smith; Nicola Veronese; Damiano Pizzol; Yvonne Barnett; Trish Gorely; Shahina Pardhan
Journal:  Eye (Lond)       Date:  2021-07-16       Impact factor: 4.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.